The effect of Fc glycan forms on human IgG2 antibody clearance in humans
- 12 November 2008
- journal article
- Published by Oxford University Press (OUP) in Glycobiology
- Vol. 19 (3), 240-249
- https://doi.org/10.1093/glycob/cwn120
Abstract
Several studies using a variety of approaches have investigated the impact of the Fc glycan structure on IgG clearance rates. Most, but not all, of these studies have concluded that glycan structural differences do not affect clearance. Here we investigated the impact of glycan on the clearance of a human antibody in humans. To monitor glycan-dependent changes, a human IgG2 was affinity purified in a single step from serum samples from a human pharmacokinetic study. The glycan profile from the purified antibody samples was determined by RP-HPLC/MS analysis of the 2-aminobenzamide-labeled glycans. Relative levels of high-mannose species (M6–M9) decreased over circulation time. Differences in the individual high-mannose structural isoform clearance rates were measured from extracted ion current profiles. Similar changes to the glycan profile could be achieved through incubation of the antibody in serum in vitro, suggesting that the changes observed in vivo were the result of glycan cleavage, not differential antibody clearance. These results confirm that antibody clearance is not significantly affected by the Fc glycan structure and provide evidence for the presence of circulating mannosidase activity in humans.Keywords
This publication has 24 references indexed in Scilit:
- Glycosylation of Recombinant Antibody TherapeuticsBiotechnology Progress, 2008
- Structural and Functional Characterization of Disulfide Isoforms of the Human IgG2 SubclassPublished by Elsevier BV ,2008
- Characterization of a complex glycoprotein whose variable metabolic clearance in humans is dependent on terminal N-acetylglucosamine contentBiologicals, 2008
- Analysis of N-glycans from recombinant immunoglobulin G by on-line reversed-phase high-performance liquid chromatography/mass spectrometryAnalytical Biochemistry, 2007
- Selective clearance of glycoforms of a complex glycoprotein pharmaceutical caused by terminal N-acetylglucosamine is similar in humans and cynomolgus monkeysGlycobiology, 2007
- Capillary electrophoresis with laser-induced fluorescence detection for detailed studies on N-linked oligosaccharide profile of therapeutic recombinant monoclonal antibodiesJournal of Chromatography A, 2006
- Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex typesGlycobiology, 2006
- Impact of variable domain glycosylation on antibody clearance: An LC/MS characterizationAnalytical Biochemistry, 2005
- The role of N‐glycosylation for the plasma clearance of rat liver secretory glycoproteinsEuropean Journal of Biochemistry, 1987
- Carbohydrate content of fragments and polypeptide chains of human .gamma.G-myeloma proteins of different heavy-chain subclassesBiochemistry, 1968